A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO CONFIRM THE AUTHENTICITY OF POINT-OF-CARE URINE SAMPLES USING ORAL FLUORESCEIN SODIUM IN ADULTS WITH SUBSTANCE USE DISORDER ¿ (THE ATTESTED STUDY)

Registry ID

UPTRU-301

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

UPTRU INC.

Start date

2026-02-10

Last update

2023-11-08

Conditions

• SUBSTANCE ABUSE

Related clinical trials

• INVESTIGATING NEUROINFLAMMATION RESPONSE IN SUBSTANCE USE DISORDER
• D3 DOPAMINE RECEPTORS IN SUBSTANCE USE DISORDER: PET STUDIES WITH [11C]-(+)PHNO
• COMPARING TREATMENTS FOR HIV-INFECTED OPIOID AND ALCOHOL USERS IN AN INTEGRATED CARE EFFECTIVENESS STUDY (CHOICES)

View on source registry